Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Boccardo F, Rubagotti A, Puntoni M, Guglielmini P, Amoroso D, Fini A, Paladini G, Mesiti M, Romeo D, Rinaldini M, Scali S, Porpiglia M, Benedetto C, Restuccia N, Buzzi F, Franchi R, Massidda B, Distante V, Amadori D, Sismondi P. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2005 Aug 1;23(22):5138-47. doi: 10.1200/JCO.2005.04.120. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009955 Clinical Trial.
Switching to aromatase inhibitors in early breast cancer.
Boccardo F, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3. Lancet. 2007. PMID: 17307082 No abstract available.
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.
Boccardo F, Amadori D, Guglielmini P, Sismondi P, Farris A, Agostara B, Gambi A, Catalano G, Faedi M, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Oncology. 2010;78(3-4):274-81. doi: 10.1159/000315735. Epub 2010 Jun 8. Oncology. 2010. PMID: 20530973 Clinical Trial.
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer.
Boccardo F, Guglielmini P, Parodi A, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Breast Cancer Res Treat. 2011 Apr;126(3):653-61. doi: 10.1007/s10549-011-1405-6. Epub 2011 Feb 24. Breast Cancer Res Treat. 2011. PMID: 21347647 Clinical Trial.
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.it.
Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Romeo D, Sismondi P, Giai M, Genta F, Pacini P, Distante V, Bolognesi A, Aldrighetti D, Farris A. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2000 Jul;18(14):2718-27. doi: 10.1200/JCO.2000.18.14.2718. J Clin Oncol. 2000. PMID: 10894871 Clinical Trial.
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial.
Ballestrero A, Rubagotti A, Stura P, Ferrando F, Amoroso D, Rinaldini M, Sismondi P, Genta F, Mesiti M, Brema F, Patrone F, Boccardo F; GROCTA (Italian Breast Cancer Adjuvant Study). Ballestrero A, et al. Among authors: rubagotti a. Oncology. 2001;60(3):221-7. doi: 10.1159/000055322. Oncology. 2001. PMID: 11340373
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Romeo D, Caroti C, Farris A, Cruciani G, Villa E, Schieppati G, Mustacchi G; Italian Breast Cancer Cooperative Group. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2001 Nov 15;19(22):4209-15. doi: 10.1200/JCO.2001.19.22.4209. J Clin Oncol. 2001. PMID: 11709564 Clinical Trial.
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Boccardo F, Rubagotti A, Battaglia M, Di Tonno P, Selvaggi FP, Conti G, Comeri G, Bertaccini A, Martorana G, Galassi P, Zattoni F, Macchiarella A, Siragusa A, Muscas G, Durand F, Potenzoni D, Manganelli A, Ferraris V, Montefiore F. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2005 Feb 1;23(4):808-15. doi: 10.1200/JCO.2005.12.013. J Clin Oncol. 2005. PMID: 15681525 Clinical Trial.
121 results